The present research aims to describe the characteristics of the withdrawal of the market of pharmaceutical products, medical devices and sanitary products in a Pharmaceutical Establishment of Trujillo. It is a descriptive, transversal and retrospective research. It consisted of the immobilization and withdrawal of 11 pharmaceutical products from 4 Laboratories. Of which the following results were obtained: Eurofarma, with 4 immobilized products; AMLOCAR 5 mg tablet, with 2906 units collected; Followed by Markos with its product UROBAC FORTE Cja x 200 tablets, with 23256 units collected, Medifarma with the product GASEOVET chewable tablet, with 1369 units collected and finally the laboratory Roemmers with its product OVUDATE Cja x 60 ova, during the period 2016. Concluding that the highest percentage of immobilizations and withdrawals of pharmaceutical products is due to the voluntary su...

This report was made with the objective of determining compliance with the current regulations of the Law on Pharmaceutical Products, Medical Devices and Health Products No. 29459 and its regulation D.S. No. 016-2011-SA; subject to registration, control and sanitary surveillance of refrigerated pharmaceutical products in a pharmaceutical distributor of La Libertad. The cold chain for refrigerated pharmaceutical products is of vital importance in the conservation and maintenance of its quality, being the storage stage the longest, and where the cold or refrigerated chamber acquires greater importance. These cold chambers correspond to large refrigeration equipment, intended for the storage of pharmaceutical products in a temperature range of 2 to 8 ° C, which is constantly monitored by the use of different devices. During this work the qualification of an adequate storage was made, throu...